LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Replicate Assay Well Timepoint Timepoint Unit Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Relative Growth Rate After Treatment
SK-BR-3 CP466722
0.12
uM
LJP5
 1
I11
 72
hr
 1401 5014 4223 1.1873 1.2803
MDA-MB-231 PD173074
0.37
uM
LJP6
 2
I10
 72
hr
 1235 5433 4513 1.2037 1.2805
SK-BR-3 LDN-193189
0.04
uM
LJP5
 3
G06
 72
hr
 1401 5016 4223 1.1878 1.2810
SK-BR-3 XL147
1.11
uM
LJP5
 2
G09
 72
hr
 1401 5030 4223 1.1911 1.2860
BT-20 YM 201636
0.04
uM
LJP5
 2
N12
 72
hr
 1097 4561 3769 1.2100 1.2962
SK-BR-3 TWS119
0.04
uM
LJP5
 1
M06
 72
hr
 1401 5060 4223 1.1982 1.2966
SK-BR-3 Enzastaurin
0.37
uM
LJP5
 2
D16
 72
hr
 1401 5062 4223 1.1986 1.2973
MCF7 SU11274
0.04
uM
LJP5
 3
J12
 72
hr
 1209 4955 4093 1.2106 1.2989
BT-20 XL147
0.04
uM
LJP5
 3
G12
 72
hr
 1097 4581 3769 1.2153 1.3037
SK-BR-3 Nilotinib
1.11
uM
LJP5
 3
N15
 72
hr
 1401 5113 4223 1.2107 1.3154
BT-20 Enzastaurin
10.0
uM
LJP5
 3
D13
 72
hr
 1097 4613 3769 1.2238 1.3156
SK-BR-3 SB590885
3.33
uM
LJP5
 3
L14
 72
hr
 1401 5140 4223 1.2171 1.3250
SK-BR-3 CP466722
0.37
uM
LJP5
 1
I10
 72
hr
 1401 5159 4223 1.2216 1.3317
SK-BR-3 XL147
3.33
uM
LJP5
 1
G08
 72
hr
 1401 5165 4223 1.2230 1.3338
SK-BR-3 XL147
0.12
uM
LJP5
 1
G11
 72
hr
 1401 5210 4223 1.2337 1.3498
BT-20 Enzastaurin
3.33
uM
LJP5
 3
D14
 72
hr
 1097 4707 3769 1.2487 1.3508
SK-BR-3 Nilotinib
0.37
uM
LJP5
 3
N16
 72
hr
 1401 5264 4223 1.2465 1.3689
SK-BR-3 Nilotinib
0.12
uM
LJP5
 3
N17
 72
hr
 1401 5276 4223 1.2493 1.3732
SK-BR-3 CP466722
0.04
uM
LJP5
 1
I12
 72
hr
 1401 5290 4223 1.2526 1.3781
SK-BR-3 XL147
0.37
uM
LJP5
 1
G10
 72
hr
 1401 5312 4223 1.2578 1.3859